Plasma Neuropeptide Y Levels in Medication Naive Adolescents with Major Depressive Disorder


Gulec M. Y. , Ozalmete O. A. , Ozturk M., Gulec H., Sayar K., KÖSE A.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.20, sa.2, ss.132-138, 2010 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 20 Konu: 2
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1080/10177833.2010.11790647
  • Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
  • Sayfa Sayıları: ss.132-138

Özet

Objective: Neuropeptide Y (NPY) has been implicated in pathophysiology of anxiety and depression. It was proposed that NPY counteracts corticotropin-releasing factor-mediated stress effects to maintain emotional regulation. We investigated NPY concentrations in a sample of first episode medication-naive adolescent patients with MDD with regards to their history of suicide attempts.